The ERA PerMed JTC2022 Midterm Symposium, held on 3–4 February 2026 in Paris, brought together researchers, clinicians, funders, and patient engagement experts to discuss the progress and interim outcomes of projects funded under the ERA PerMed Joint Transnational Call 2022.
The symposium featured presentations from the 24 multinational interdisciplinary consortia supported through the JTC2022 “Prevention in Personalised Medicine”, which aims to advance personalised approaches to disease prevention and early intervention. The scientific programme was chaired by Tuula Kallunki, Francesco Papaleo, György Sándor, and Edyta Pawlak, whose expertise ensured focused discussions and high-quality scientific exchange across sessions.
Over two days, participants explored a wide range of prevention-oriented research topics across disease areas including cancer, neurological and neuropsychiatric disorders, cardiovascular and metabolic diseases, kidney and bladder diseases, immune and infectious conditions. Presentations highlighted innovative approaches such as biomarker discovery, risk stratification, data-driven prediction models, and personalised preventive strategies, illustrating the breadth and interdisciplinarity of the funded projects.
The programme included an interactive thematic round-table workshop with four thematic tables addressing research, innovation, implementation, and ethical and social aspects of personalised prevention. This session provided a forum for open exchange on balancing scientific research and innovation with feasibility and real-world impact.
JTC2022 Project Booklet
A dedicated workshop entitled “AI for Personalised Medicine: Bridging the Gap Between Innovation and Implementation” was delivered by Prof. Stéphanie Allassonnière (University Paris Cité). The workshop explored the role of artificial intelligence in supporting personalised medicine and in translating research outputs into clinical decision-making and healthcare practice. Through the presentation of real-world examples, it illustrated how AI-based tools can support clinical care, while also highlighting the significant gap between the development of such tools and their implementation in routine practice. Key challenges discussed included regulatory requirements, validation processes, and other systemic barriers that must be addressed to enable successful adoption.
Patient engagement was a central component of the symposium. Two patient engagement experts, Maria José Ruiz and Letizia Pontoriero, contributed to discussions on integrating patient perspectives into the personalised medicine research performed by the funded projects. Following the project presentations, they posed project-specific questions and shared practical insights on strengthening meaningful patient involvement across the research lifecycle.
Poster sessions provided a platform for early-career researchers from the funded consortia to present their work and engage in scientific exchange. Participants were invited to vote for the best poster, recognising excellence in scientific communication and research quality. The winner of the poster prize was Alessia Berni from the MG-PerMed project.
The symposium also featured the JTC2022 Video Competition Award, presented to the young researchers of the DAWN-AF consortium for their video “DAWN-AF: Digital Twins to Treat Atrial Fibrillation”. Produced by Tomas Banduc (Pontificia Universidad Católica de Chile) and Hamed Hosseini (University of Bordeaux, LIRYC Institute), the video demonstrated how AI-enhanced mathematical modelling can support personalised treatment strategies and improve clinical outcomes. The award session opened with a screening of the video, after which Hamed Hosseini gave a short presentation reflecting on his research and on how participating in a large, interdisciplinary consortium had contributed to his professional development. The session concluded with the formal presentation of the award.
By bringing together researchers, clinicians, patient engagement experts, and funding organisations, the JTC2022 Midterm Symposium fostered cross-project exchange, interdisciplinary dialogue, and reflection on implementation challenges. The meeting reinforced EP PerMed’s role in supporting excellent transnational research and advancing prevention-oriented personalised medicine for the benefit of patients and healthcare systems.
For more details on the projects presented, please see the Midterm Seminar booklet .